Rifalazil
Rifalazil is an antibiotic that belongs to the rifamycin group. It is primarily used in the treatment of tuberculosis and other bacterial infections.
History[edit]
Rifalazil was first synthesized in the 1980s by the pharmaceutical company Hoffmann-La Roche. It was developed as a part of the company's efforts to create new antibiotics that could combat drug-resistant strains of bacteria.
Mechanism of Action[edit]
Rifalazil works by inhibiting the RNA polymerase enzyme in bacteria, which is essential for the synthesis of RNA and protein. By blocking this enzyme, the antibiotic prevents the bacteria from growing and reproducing.
Clinical Use[edit]
Rifalazil is used in the treatment of various bacterial infections, including tuberculosis, leprosy, and Legionnaires' disease. It is also used in the treatment of Chlamydia pneumoniae, a common cause of pneumonia.
Side Effects[edit]
Like all antibiotics, Rifalazil can cause side effects. The most common side effects include nausea, vomiting, and diarrhea. In rare cases, it can cause more serious side effects such as liver damage or allergic reactions.
Resistance[edit]
Bacterial resistance to Rifalazil is a growing concern. Resistance occurs when bacteria evolve mechanisms to survive exposure to the antibiotic. This can occur through the mutation of the RNA polymerase enzyme, rendering Rifalazil ineffective.
See Also[edit]
|
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
 | This medical article is a stub. You can help WikiMD by expanding the page. |
-
Rifalazil chemical structure
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
